Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Delix Therapeutics
Recent news which mentions Delix Therapeutics
Psilocybin Drug By Psilera Could Treat Frontotemporal Dementia Without Psychoactive Effects
September 09, 2024
Tickers
NEWS
Tags
Psilocybin
News
Onsero Therapeutics
From
Benzinga
Delix's Non-Hallucinogen Completes Safe Administration To First Clinical Trial Cohort
June 20, 2023
Tags
depression treatment
Management
Market News
From
Benzinga
Delix's Non-Hallucinogenic Psychoplastogen Enters Phase 1 Trial
May 09, 2023
Tags
Delix Therapeutics
Market News
Next/Generation Psychedelics
From
Benzinga
Delix: Elucidating How Psychedelics Actually Induce Neuroplasticity Vs. SSRIs
February 17, 2023
Tags
David Olson
Guidance
Market News
From
Benzinga
Delix Inks Deal With Cellectricon; Psyched Wellness Partners With Spacestation
February 16, 2023
Tickers
PSYCF
Tags
News
Offerings
Penny Stocks
From
Benzinga
Psychedelics Companies Share Corporate Updates: Numinus, Delix, Tryp And Small Pharma
September 14, 2022
Tickers
DMTTF
NUMIF
TRYPF
Tags
Delix Therapeutics
Market News
John Nesbett
From
Benzinga
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
Tickers
ATAI
AWKNF
CYBN
FTRP
Tags
Topics
Cannabis
Small Cap
From
Benzinga
Delix Therapeutics Raises $30M In Convertible Note Financing, Will Enhance Drug Development Program
January 11, 2022
Tags
Biotech
Cannabis
Markets
From
Benzinga
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
Tickers
ATAI
NVMDF
Tags
Biotech
ATAI Life Sciences
Delix Therapeutics
From
Benzinga
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
October 04, 2021
Tickers
BRAXF
FTRP
MCURF
NVMDF
Tags
MCURF
BRAXF
Market News
From
Benzinga
'Psychedelics Without Hallucinations': Concept Get Closer To Human Trials With $70M Funding
September 27, 2021
Tags
Market News
Delix Therapeutics
Markets
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.